GlassScriptPhysician profile
Stephanie Harris
NPI 1457762148
$1,894.59
in general payments reported to CMS, 2019-2025
24 companies · $737 in 2025
The $737 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $44.74 · 2021: $14.89 · 2022: $205 · 2023: $236 · 2024: $491 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.62 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $346.85 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $261.12 | 2023-2025 | Myfembree |
| Organon LLC | $183.64 | 2022-2025 | Nexplanon, Jada System |
| Abbvie INC. | $163.90 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $136.03 | 2024 | |
| Biogen, INC. | $117.75 | 2024-2025 | Zurzuvae |
| Octapharma USA, INC. | $83.72 | 2025 | Fibryga |
| Daiichi Sankyo INC. | $75.71 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.57 | 2019-2025 | |
| Exeltis, USA INC. | $58.08 | 2023-2025 | Slynd |
| Coopersurgical, INC. | $48.59 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $46.32 | 2025 | |
| Pfizer INC. | $42.34 | 2022-2023 | |
| Myovant Sciences INC. | $39.49 | 2022 | |
| Agile Therapeutics, INC. | $37.95 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $30.51 | 2024 | Acessa Provu System, Omni Hysteroscope, Coolseal Generator |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.85 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.18 | 2019-2024 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $26.31 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $24.16 | 2019 | |
| Insulet Corporation | $15.26 | 2019 | |
| Exact Sciences Corporation | $14.87 | 2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $14.07 | 2019 | |
| Amgen INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.